0,989  0,002  Skin irritative effect
0,924  0,004  Carcinogenic
0,904  0,004  TNF expression inhibitor
0,904  0,005  Antiinflammatory
0,889  0,004  Chemoprotective
0,870  0,009  Apoptosis agonist
0,831  0,004  Cardioprotectant
0,827  0,004  Eye irritation, high
0,820  0,005  GST A substrate
0,810  0,004  Lipoprotein disorders treatment
0,787  0,013  Caspase 9 stimulant
0,770  0,007  Antihypercholesterolemic
0,766  0,006  Mutagenic
0,764  0,004  UDP-glucuronosyltransferase substrate
0,758  0,012  Antineoplastic (lung cancer)
0,741  0,004  Antineoplastic (lymphoma)
0,742  0,004  AR expression inhibitor
0,740  0,005  Bone diseases treatment
0,737  0,005  Antiosteoporotic
0,717  0,009  Chemopreventive
0,707  0,004  Antiulcerative
0,706  0,005  Nitric oxide antagonist
0,695  0,006  Spasmolytic
0,687  0,022  Transcription factor NF kappa B inhibitor
0,673  0,017  Embryotoxic
0,650  0,008  Antioxidant
0,646  0,005  Antineoplastic (multiple myeloma)
0,641  0,005  Hypolipemic
0,636  0,005  Antineoplastic enhancer
0,636  0,005  Antifungal
0,636  0,006  Antiprotozoal (Leishmania)
0,633  0,005  Antihelmintic
0,638  0,011  Atherosclerosis treatment
0,634  0,009  Antiparasitic
0,630  0,008  Antipsoriatic
0,598  0,004  Lipid peroxidase inhibitor
0,607  0,023  15-Lipoxygenase inhibitor
0,579  0,014  Proliferative diseases treatment
0,570  0,007  Renal disease treatment
0,540  0,003  Abortion inducer
0,555  0,020  Vasodilator, peripheral
0,548  0,014  NOS2 expression inhibitor
0,546  0,015  Caspase 3 stimulant
0,570  0,040  Antineoplastic (breast cancer)
0,556  0,027  Antibacterial
0,542  0,014  Antineoplastic (brain cancer)
0,542  0,015  CYP2C19 inhibitor
0,528  0,001  Papain-like protease (SARS coronavirus) inhibitor
0,531  0,006  Genotoxic
0,544  0,021  Antineoplastic (ovarian cancer)
0,519  0,010  Vasodilator
0,516  0,019  Hepatic disorders treatment
0,503  0,007  Melanin inhibitor
0,519  0,027  Antithrombotic
0,508  0,019  NOS3 expression inhibitor
0,494  0,004  GST P1-1 substrate
0,529  0,042  Antidiabetic
0,529  0,042  Cyclophilin D inhibitor
0,511  0,026  CYP2C19 substrate
0,518  0,037  Antileukemic
0,491  0,011  Sedative
0,506  0,027  Stroke treatment
0,478  0,004  Electron transport complex I inhibitor
0,505  0,032  Immunosuppressant
0,504  0,032  Teratogen
0,479  0,008  Skin whitener
0,481  0,013  Antihypertriglyceridemic
0,487  0,027  Inflammatory Bowel disease treatment
0,473  0,017  Antiglaucomic
0,476  0,025  Radioprotector
0,452  0,004  Neurotrophic factor enhancer
0,467  0,024  Lipoxygenase inhibitor
0,479  0,036  Cholesterol antagonist
0,473  0,032  Respiratory analeptic
0,444  0,005  Antidiabetic (type 1)
0,457  0,025  Cytostatic
0,435  0,004  Gastrin inhibitor
0,456  0,025  UGT1A9 substrate
0,448  0,020  CYP3A4 inhibitor
0,420  0,009  UGT2B7 substrate
0,436  0,026  Antituberculosic
0,442  0,033  Immunomodulator
0,435  0,031  Analeptic
0,439  0,035  FMO1 substrate
0,453  0,049  Antiprotozoal
0,413  0,010  GST M1-1 substrate
0,430  0,032  Antineoplastic (cervical cancer)
0,400  0,004  Cholesterol synthesis inhibitor
0,403  0,010  Antieczematic atopic
0,406  0,016  UGT1A1 substrate
0,423  0,034  Antimycobacterial
0,396  0,009  Amylase inhibitor
0,425  0,038  CYP2D6 substrate
0,406  0,021  Myocardial infarction treatment
0,387  0,004  TRPA1 agonist
0,416  0,034  Antineoplastic (pancreatic cancer)
0,428  0,046  Prostate cancer treatment
0,427  0,046  Angiogenesis inhibitor
0,384  0,004  Antieczematic
0,391  0,014  Hepatoprotectant
0,421  0,044  Immunostimulant
0,406  0,035  Cytotoxic
0,429  0,061  Histamine release inhibitor
0,397  0,029  Radiosensitizer
0,369  0,005  UGT2B9 substrate
0,365  0,004  Alcohol dehydrogenase substrate
0,372  0,014  Antineoplastic (squamous cell carcinoma)
0,413  0,056  GABA C receptor rho-3 antagonist
0,394  0,037  Antineoplastic (glioma)
0,370  0,014  Antiacne
0,359  0,008  Acute respiratory distress syndrome (ARDS) treatment
0,354  0,007  Protein-tyrosine phosphatase 1B inhibitor
0,352  0,014  VCAM1 expression inhibitor
0,355  0,018  Contraceptive
0,339  0,007  Antifungal enhancer
0,334  0,004  Gastric antisecretory
0,364  0,038  Huntington's disease treatment
0,337  0,014  Protein-tyrosine phosphatase inhibitor
0,360  0,040  Sensitization
0,335  0,018  Antineoplastic (carcinoma)
0,406  0,090  Antiarthritic
0,322  0,007  Neurotrophic factor
0,352  0,039  Antiprotozoal (Trypanosoma)
0,316  0,011  Glutathione S-transferase substrate
0,346  0,045  UGT2B4 substrate
0,373  0,078  Antipruritic, allergic
0,309  0,016  CYP2B6 inhibitor
0,319  0,028  Platelet adhesion inhibitor
0,323  0,036  Antineoplastic (lymphocytic leukemia)
0,329  0,044  Platelet antagonist
0,326  0,043  Antineoplastic (renal cancer)
0,284  0,002  Glycine receptor agonist
0,322  0,046  Free radical scavenger
0,294  0,018  Monophenol monooxygenase inhibitor
0,320  0,051  Antihypoxic
0,272  0,010  Antihemorrhagic
0,285  0,023  UGT1A3 substrate
0,327  0,068  Apoptosis antagonist
0,305  0,046  Acute neurologic disorders treatment
0,269  0,012  Uterine stimulant
0,252  0,005  Arachidonic acid antagonist
0,280  0,034  UGT1A4 substrate
0,265  0,026  Interferon gamma antagonist
0,245  0,009  Antiinfertility, female
0,240  0,011  Microtubule formation inhibitor
0,236  0,009  Contraceptive female
0,291  0,069  FMO3 substrate
0,289  0,068  Antidiabetic (type 2)
0,244  0,024  LDLR expression enhancer
0,222  0,005  Antiviral (SARS coronavirus)
0,222  0,005  Antiviral (Coronavirus)
0,243  0,031  Hair growth stimulant
0,216  0,004  Ca(v)3.1 blocker
0,226  0,015  Farnesoid X receptor antagonist
0,214  0,003  Glycine receptor antagonist
0,313  0,108  Antiobesity
0,225  0,022  UGT2B10 substrate
0,261  0,058  Tyrosine 3 hydroxylase inhibitor
0,207  0,005  Lipase inhibitor
0,344  0,144  Antineoplastic (solid tumors)
0,202  0,002  Squalene synthetase inhibitor
0,210  0,013  Coagulant
0,229  0,032  Protein kinase stimulant
0,264  0,069  Hypoglycemic
0,283  0,088  Antineoplastic (colorectal cancer)
0,260  0,068  Cardiovascular analeptic
0,259  0,068  Antineoplastic (liver cancer)
0,232  0,043  Antimutagenic
0,198  0,011  Antiviral (Influenza B)
0,221  0,035  Succinate dehydrogenase inhibitor
0,247  0,063  Antineoplastic (glioblastoma multiforme)
0,196  0,015  Antineoplastic alkaloid
0,228  0,049  Insulin sensitizer
0,247  0,068  DNA synthesis inhibitor
0,249  0,071  Angiogenesis stimulant
0,241  0,066  UGT1A6 substrate
0,263  0,089  Antineoplastic (colon cancer)
0,195  0,022  Antineoplastic antibiotic
0,180  0,007  Anabolic
0,247  0,076  Antidiabetic symptomatic
0,180  0,008  Vanilloid agonist
0,212  0,042  Antiviral (Herpes)
0,204  0,035  Bone formation stimulant
0,198  0,030  Cell wall synthesis inhibitor
0,185  0,017  Vanilloid 1 agonist
0,199  0,033  Hemostatic
0,195  0,030  DNA polymerase I inhibitor
0,188  0,025  Antifungal (Cryptococcus)
0,190  0,027  Cell adhesion inhibitor
0,185  0,022  Adenylate cyclase stimulant
0,199  0,043  Phospholipase A2 inhibitor
0,248  0,094  Antineoplastic (melanoma)
0,203  0,050  Antineoplastic (gastric cancer)
0,208  0,056  Antipruritic, non-allergic
0,159  0,008  Phosphodiesterase 6D inhibitor
0,210  0,063  Non-steroidal antiinflammatory agent
0,176  0,030  Antibacterial (Helicobacter pylori)
0,176  0,030  Hearing loss treatment
0,155  0,009  TRPA1 antagonist
0,154  0,008  Tourette's syndrome treatment
0,164  0,019  Ca2+-transporting ATPase inhibitor
0,173  0,029  Ferrochelatase inhibitor
0,196  0,054  Thrombolytic
0,230  0,089  Superoxide dismutase inhibitor
0,145  0,004  Prostaglandin agonist
0,148  0,007  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,171  0,033  Cyclooxygenase 3 inhibitor
0,158  0,020  Androgen antagonist
0,153  0,015  Inducible nitric-oxide synthase inhibitor
0,207  0,070  Anesthetic general
0,217  0,086  Antihypotensive
0,133  0,003  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,175  0,045  Carcinogenic, group 3
0,164  0,035  Autism spectrum disorders treatment
0,145  0,017  UGT2B11 substrate
0,225  0,097  Chronic obstructive pulmonary disease treatment
0,211  0,084  RNA-directed DNA polymerase inhibitor
0,258  0,132  Antiprotozoal (Plasmodium)
0,199  0,075  Pneumotoxic
0,227  0,103  Amyotrophic lateral sclerosis treatment
0,169  0,045  Alpha-N-acetylglucosaminidase inhibitor
0,145  0,022  Triose-phosphate isomerase inhibitor
0,228  0,106  5 Hydroxytryptamine uptake stimulant
0,141  0,020  Phosphofructokinase-1 inhibitor
0,125  0,005  Farnesyltransferase inhibitor
0,251  0,131  CYP3A4 substrate
0,149  0,030  GABA C receptor antagonist
0,208  0,089  Peptidyltransferase inhibitor
0,155  0,037  Carcinogenic, group 2B
0,136  0,019  Transcription factor NF kappa B stimulant
0,229  0,113  Antiepileptic
0,242  0,127  Antiallergic
0,122  0,008  Hypercalcemia treatment
0,143  0,029  Adenylate kinase inhibitor
0,129  0,018  Antifungal (Candida)
0,128  0,017  Antiprotozoal activity enhancer
0,130  0,019  Ornithine decarboxylase inhibitor
0,112  0,004  Squalene epoxidase inhibitor
0,122  0,015  Na+ K+ transporting ATPase inhibitor
0,229  0,122  12-Lipoxygenase inhibitor
0,142  0,037  GABA C receptor agonist
0,125  0,022  Cell adhesion molecule inhibitor
0,214  0,112  Flavin-containing monooxygenase substrate
0,122  0,022  Glutamate dehydrogenase inhibitor
0,150  0,052  Pregnane X receptor agonist
0,248  0,151  CYP2C9 substrate
0,162  0,066  Carcinogenic, group 1
0,158  0,063  GABA C receptor rho-2 antagonist
0,209  0,114  5 Hydroxytryptamine release stimulant
0,121  0,028  Antiviral (Rhinovirus)
0,131  0,039  Mediator release inhibitor
0,119  0,029  Antidote, mercury
0,129  0,040  Bronchodilator
0,167  0,077  Phospholipase C inhibitor
0,097  0,011  Leukotriene B4 antagonist
0,097  0,010  Exportin-1 inhibitor
0,109  0,023  Peroxisome proliferator-activated receptor gamma agonist
0,099  0,016  Neuraminidase inhibitor
0,106  0,024  CDC25A inhibitor
0,150  0,069  UGT2B15 substrate
0,084  0,003  Prostaglandin D2 agonist
0,119  0,038  Nitric-oxide synthase inhibitor
0,124  0,044  UGT2B1 substrate
0,222  0,142  CTGF expression inhibitor
0,082  0,004  Kainate receptor agonist
0,119  0,041  GABA C receptor rho-1 antagonist
0,185  0,108  Antiviral (HIV)
0,150  0,073  Antiviral (Influenza A)
0,081  0,005  Membrane dipeptidase inhibitor
0,237  0,162  Calcium channel activator
0,107  0,035  Bile acid receptor antagonist
0,111  0,039  Carcinogenic, group 2A
0,077  0,005  Geranyltranstransferase inhibitor
0,122  0,052  Aldehyde dehydrogenase substrate
0,082  0,012  CD45 antagonist
0,117  0,047  Toll-Like receptor 4 antagonist
0,098  0,029  Antiviral (Dengue virus)
0,115  0,046  GST T1-1 substrate
0,091  0,022  Peroxisome proliferator-activated receptor gamma antagonist
0,073  0,005  Parathyroid hormone antagonist
0,088  0,021  Neuraminidase (influenza) inhibitor
0,074  0,008  Fumarate hydratase inhibitor
0,101  0,035  CYP2A6 inhibitor
0,184  0,118  Antineoplastic (non-small cell lung cancer)
0,074  0,008  Nicotinic acid receptor agonist
0,165  0,100  Antiarrhythmic
0,105  0,039  Antispirochetal
0,085  0,020  Acyl-CoA dehydrogenase inhibitor
0,075  0,012  Anesthetic inhalation
0,084  0,022  Androgen agonist
0,155  0,093  ATPase inhibitor
0,073  0,011  Pregnane X receptor antagonist
0,093  0,032  GABA aminotransferase inhibitor
0,084  0,024  Prostaglandin EP2 antagonist
0,114  0,054  Antiviral (Poxvirus)
0,076  0,016  Postcoital contraceptive
0,091  0,032  Narcotic antagonist
0,094  0,037  Antibiotic
0,073  0,017  Aconitate hydratase inhibitor
0,070  0,014  Vanilloid 2 antagonist
0,143  0,088  Movement disorders treatment
0,058  0,005  Prostaglandin EP4 agonist
0,060  0,006  Retinoid X receptor antagonist
0,165  0,112  Anticonvulsant
0,110  0,056  5-Lipoxygenase inhibitor
0,057  0,005  HMG CoA reductase inhibitor
0,080  0,029  Carbamoyl phosphate synthetase inhibitor
0,152  0,102  DNA methyltransferase I inhibitor
0,195  0,146  Antiischemic
0,078  0,030  CDC25B inhibitor
0,075  0,027  Andropause treatment
0,052  0,005  Retinoid X alpha receptor antagonist
0,086  0,039  Histone deacetylase SIRT1 stimulant
0,086  0,039  Histone deacetylase stimulant
0,066  0,019  Glucose-6-phosphate translocase inhibitor
0,092  0,045  Glutathione S-transferase inhibitor
0,079  0,032  Hyperparathyroidism treatment
0,062  0,017  Glucose-6-phosphate isomerase inhibitor
0,048  0,005  Geranylgeranyltransferase I inhibitor
0,048  0,004  Vitamin D receptor antagonist
0,206  0,164  Antihypertensive
0,111  0,069  Photosensitizer
0,131  0,089  Corneal wound healing stimulator
0,076  0,035  Leukotriene antagonist
0,046  0,006  Prostaglandin EP2 agonist
0,098  0,058  Prolactin inhibitor
0,055  0,016  Retinoid X receptor agonist
0,080  0,041  Phosphodiesterase VI inhibitor
0,113  0,075  Alkylator
0,041  0,003  Neuraminidase (Influenza B) inhibitor
0,068  0,031  Argininosuccinate synthase inhibitor
0,046  0,009  ATP citrate lysase inhibitor
0,041  0,005  Prostaglandin F2 alpha agonist
0,060  0,026  Peroxisome proliferator-activated receptor alpha agonist
0,075  0,042  Phospholipase D inhibitor
0,039  0,007  Prostaglandin E2 agonist
0,148  0,118  Cardiodepressant
0,065  0,036  Biliverdin reductase inhibitor
0,049  0,020  Liver X receptor alpha agonist
0,076  0,048  Glutamate decarboxylase inhibitor
0,045  0,016  Retinoid X alpha receptor agonist
0,061  0,033  Lipocortins synthesis agonist
0,035  0,007  Retinoid X gamma receptor antagonist
0,058  0,032  Dihydroorotate oxidase inhibitor
0,036  0,010  Peroxisome proliferator-activated receptor alpha antagonist
0,054  0,029  Lysophosphatidic acid 3 receptor antagonist
0,029  0,005  Retinoid X beta receptor antagonist
0,127  0,103  Urolithiasis treatment
0,051  0,027  Microtubule stabilization
0,113  0,091  Gastritis treatment
0,081  0,059  Thioredoxin reductase inhibitor
0,074  0,052  Porphobilinogen synthase inhibitor
0,069  0,047  Phenylalanine 4-hydroxylase inhibitor
0,043  0,021  TRPM8 blocker
0,111  0,090  Anesthetic
0,093  0,072  Protease inhibitor
0,047  0,026  Liver X receptor agonist
0,067  0,046  Glutamate (mGluR6) antagonist
0,153  0,134  Growth factor agonist
0,125  0,106  NOS3 expression enhancer
0,062  0,043  Antimycoplasmal
0,200  0,182  Vasodilator, coronary
0,029  0,010  Retinoic acid receptor agonist
0,092  0,074  Sulfotransferase substrate
0,074  0,057  Keratolytic
0,105  0,087  Antiseptic
0,024  0,007  Prostacyclin agonist
0,152  0,135  Antiparkinsonian, rigidity relieving
0,148  0,131  Antirickettsial
0,053  0,037  Ornithine carbamoyltransferase inhibitor
0,048  0,032  Aldosterone antagonist
0,096  0,083  Mucolytic
0,089  0,076  Electrolyte absorption antagonist
0,019  0,008  Vitamin D receptor agonist
0,024  0,013  Geranylgeranyltransferase inhibitor
0,141  0,132  P-glycoprotein inhibitor
0,021  0,013  Inosine monophosphate dehydrogenase 1 inhibitor
0,031  0,023  Cholesterol ester transfer protein antagonist
0,040  0,033  Cholesterol absorption inhibitor
0,027  0,021  LFA antagonist
0,018  0,012  Potassium channel (Inward rectifier) 11 blocker
0,071  0,066  Estrogen receptor alpha antagonist
0,047  0,043  Ribonucleoside-diphosphate reductase inhibitor
0,042  0,038  Neuraminidase (Influenza A) inhibitor
0,030  0,026  Methionyl aminopeptidase 1 inhibitor
0,175  0,172  Transcription factor STAT3 inhibitor
0,062  0,060  Prostaglandin-E synthase inhibitor
0,116  0,114  SULT1A3 substrate
0,004  0,003  Vitamin D-like

